ATE316101T1 - Thrombinspaltbare faktor-x-analoga - Google Patents

Thrombinspaltbare faktor-x-analoga

Info

Publication number
ATE316101T1
ATE316101T1 AT03762681T AT03762681T ATE316101T1 AT E316101 T1 ATE316101 T1 AT E316101T1 AT 03762681 T AT03762681 T AT 03762681T AT 03762681 T AT03762681 T AT 03762681T AT E316101 T1 ATE316101 T1 AT E316101T1
Authority
AT
Austria
Prior art keywords
analogues
thrombin
factor
splitting factor
arg
Prior art date
Application number
AT03762681T
Other languages
English (en)
Inventor
Virginie Louvain
Elsa Bianchini
Pierre-Emmanuel Marque
Claire Calmel-Tareau
Martine Aiach
Bonniec Bernard Le
Original Assignee
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of ATE316101T1 publication Critical patent/ATE316101T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6432—Coagulation factor Xa (3.4.21.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21006—Coagulation factor Xa (3.4.21.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT03762681T 2002-07-03 2003-06-30 Thrombinspaltbare faktor-x-analoga ATE316101T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0208299A FR2841904B1 (fr) 2002-07-03 2002-07-03 Analogues de facteurs x clivables par la thrombine

Publications (1)

Publication Number Publication Date
ATE316101T1 true ATE316101T1 (de) 2006-02-15

Family

ID=29725108

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03762681T ATE316101T1 (de) 2002-07-03 2003-06-30 Thrombinspaltbare faktor-x-analoga

Country Status (10)

Country Link
US (1) US8168753B2 (de)
EP (1) EP1539816B1 (de)
JP (1) JP4533137B2 (de)
AT (1) ATE316101T1 (de)
AU (1) AU2003250095B2 (de)
CA (1) CA2491040C (de)
DE (1) DE60303312T2 (de)
ES (1) ES2257693T3 (de)
FR (1) FR2841904B1 (de)
WO (1) WO2004005347A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2831170B1 (fr) 2001-10-19 2004-03-19 Inst Nat Sante Rech Med Proteines c modifiees activables directement par la thrombine
EP1728798A1 (de) 2005-06-01 2006-12-06 ZLB Behring GmbH Blutgerinnungsfaktor X Polypeptide mit veränderten Aktivierungseigenschaften
MX2008006313A (es) * 2005-11-15 2008-11-06 Philadelphia Children Hospital Metodos y composiciones para modular la hemostasia.
EP1816201A1 (de) 2006-02-06 2007-08-08 CSL Behring GmbH Modifizierter Koagulationsfaktor VIIa mit verbesserter 'half-life'-Stabiltät
EP1820508A1 (de) 2006-02-21 2007-08-22 CSL Behring GmbH Polypeptide des Gerinnfaktors X mit geänderten Aktivierungseigenschaften
CA2673459C (en) 2006-12-22 2016-09-13 Stefan Schulte Modified coagulation factors with prolonged in vivo half-life
JP5833448B2 (ja) 2008-12-19 2015-12-16 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル セリンプロテアーゼ誘導体および血液凝固疾患の予防または処置における使用
US9371522B2 (en) 2011-09-30 2016-06-21 The Children's Hospital Of Philadelphia Compositions and methods for modulating hemostasis
WO2013185113A1 (en) 2012-06-08 2013-12-12 Biogen Idec Ma Inc. Procoagulant compounds
CA2875247A1 (en) 2012-06-08 2013-12-12 Biogen Idec Ma Inc. Chimeric clotting factors
WO2014018120A1 (en) 2012-07-25 2014-01-30 Catalyst Biosciences, Inc. Modified factor x polypeptides and uses thereof
ES2761730T3 (es) 2013-01-31 2020-05-20 Pfizer Composiciones y procedimientos para contrarrestar la inhibición del factor Xa
FR3001729B1 (fr) * 2013-02-04 2015-03-06 Lab Francais Du Fractionnement Mutants du facteur x
US20160024487A1 (en) * 2013-03-12 2016-01-28 Novo Nordisk A/S Thrombin sensitive coagulation factor x molecules
EP3049434A1 (de) 2013-09-24 2016-08-03 Pfizer Inc. Zusammensetzungen mit heterogenen populationen aus rekombinanten menschlichen proteinen mit dem gerinnungsfaktor xa
US10676731B2 (en) 2014-08-19 2020-06-09 The Children's Hospital Of Philadelphia Compositions and methods for modulating factor IX function

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS634615A (ja) * 1986-06-25 1988-01-09 Hitachi Tokyo Electron Co Ltd 半導体装置製造装置
GB9222758D0 (en) * 1992-10-29 1992-12-09 British Bio Technology Proteins and nucleic acids
US5746875A (en) * 1994-09-16 1998-05-05 Applied Materials, Inc. Gas injection slit nozzle for a plasma process reactor
US6043218A (en) * 1996-10-22 2000-03-28 Medical University Of South Carolina Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides
EP0946414B1 (de) * 1996-11-04 2005-06-29 Materials Modification, Inc. Mikrowellenplasma chemischen synthese von ultrafeinen pulvern
AT405516B (de) * 1997-02-27 1999-09-27 Immuno Ag Faktor x-analoge mit modifizierter proteasespaltstelle
CH697092A5 (de) * 1998-12-24 2008-04-30 Sulzer Metco Ag Anordnung für eine Plasmaspritzanlage.

Also Published As

Publication number Publication date
EP1539816A1 (de) 2005-06-15
US8168753B2 (en) 2012-05-01
ES2257693T3 (es) 2006-08-01
CA2491040C (en) 2012-05-01
DE60303312D1 (de) 2006-04-06
JP2006507806A (ja) 2006-03-09
DE60303312T2 (de) 2006-09-21
AU2003250095B2 (en) 2009-04-09
EP1539816B1 (de) 2006-01-18
CA2491040A1 (en) 2004-01-15
FR2841904A1 (fr) 2004-01-09
JP4533137B2 (ja) 2010-09-01
FR2841904B1 (fr) 2004-08-20
AU2003250095A1 (en) 2004-01-23
US20060148038A1 (en) 2006-07-06
WO2004005347A1 (en) 2004-01-15

Similar Documents

Publication Publication Date Title
ATE316101T1 (de) Thrombinspaltbare faktor-x-analoga
GEP20063741B (en) Nonaryl-Heterocyclic NMDA/NR2B Antagonists
CO5700784A2 (es) Polipeptidos de virus de papiloma humano y composiciones in- munogenas
DE602004031301D1 (de) Nichtsymmetrisches geliermittel
ATE446313T1 (de) Muteine von tränen-lipocalin
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
MX9300800A (es) Polimeros de beta-dicarbonilo y sistema para formar un cemento a partir de los mismos.
DE60110342D1 (de) Alpha-Interferon enthaltende Hautpflegemittel
PT1411908E (pt) Tratamento de infeccoes da unha com no
BRPI0515316A (pt) compostos de imidazoquinolina
CY1108547T1 (el) Αναλογα σωματοστατινης
ATE425253T1 (de) Tribonektine
TR200401793T4 (tr) Perindopril tuzu ve bunu içeren farmasötik bileşimler.
ATE282607T1 (de) Tryptase-inhibitoren
DE602004028246D1 (de) Analoga von peptiden der relaxin-superfamilie
ATE357245T1 (de) Biologisch stabile flüssige zusammensetzung von fviii, vwf oder fviii/vwf-komplex menschlichen ursprungs
PA8577701A1 (es) Polipeptido t20 pegilado
NO964238D0 (no) Halofantrin-fri-base for behandling av malaria og blandinger
AR006616A1 (es) Derivados carboxilicos utiles como inhibidores de los receptores de las endotelinas y composiciones farmaceuticas que los contienen
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
NO20052216L (no) Smertestillende midler
DE60309480D1 (de) Vitamin d-analoge
ATE457188T1 (de) Kompositmaterialien aus calciumverbindungen und glucuronsäurehaltigen polysacchariden
ATE487489T1 (de) Rekombinante intrazellulärepathogen-immunogene zusammensetzungen und anwendungsverfahren
HUP0300997A2 (hu) A MIA-fehérje alkalmazása immunterápiában

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties